Join to View Full Profile
730 NE Jeffries PlNewport, OR 97365
Phone+1 815-262-4294
Fax+1 541-635-5771
Dr. Geiger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mary Geiger is an Internal Medicine specialist and a graduate of the Medical College of Wisconsin, class of 1992. She has several noteworthy publications, including her work on cardiovascular outcomes and non-inferiority trials, as well as studies on heterozygous familial hypercholesterolemia, cardiovascular endpoints, and the cardiovascular risks associated with antidiabetic therapies. Her research has been cited numerous times, with publications in prominent journals such as the American Heart Journal and the European Heart Journal.
Education & Training
Medical College of WisconsinClass of 1992
Certifications & Licensure
WI State Medical License 1995 - 2023
IN State Medical License 2005 - 2019
MO State Medical License 1996 - 2014
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 7 citationsRestricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development.David H. Manner, Chakib Battioui, Stefan Hantel, B. Nhi Beasley, Lee-Jen Wei
American Heart Journal. 2019-06-06 - 430 citationsODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemiaJohn J.P. Kastelein, Henry N. Ginsberg, Gisle Langslet, G. Kees Hovingh, Richard Ceska
European Heart Journal. 2015-11-14 - 19 citationsCentralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: A report from the Cardiac Safety Research ConsortiumJonathan H. Seltzer, J. Rick Turner, Mary Jane Geiger, Giuseppe Rosano, Kenneth W. Mahaffey
American Heart Journal. 2015-02-01
Press Mentions
MBX Biosciences Appoints Mary Jane Geiger, M.D., Ph.D., as Chief Medical OfficerJanuary 5th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
